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Abstract
CD1d-restricted invariant natural killer T (iNKT) cells constitute a
common glycolipid-reactive innate-like T-cell subset with a broad
impact on innate and adaptive immunity. While several microbial
glycolipids are known to activate iNKT cells, the cellular mecha-
nisms leading to endogenous CD1d-dependent glycolipid responses
remain largely unclear. Here, we show that endoplasmic reticulum
(ER) stress in APCs is a potent inducer of CD1d-dependent iNKT cell
autoreactivity. This pathway relies on the presence of two trans-
ducers of the unfolded protein response: inositol-requiring
enzyme-1a (IRE1a) and protein kinase R-like ER kinase (PERK).
Surprisingly, the neutral but not the polar lipids generated within
APCs undergoing ER stress are capable of activating iNKT cells.
These data reveal that ER stress is an important mechanism to
elicit endogenous CD1d-restricted iNKT cell responses through
induction of distinct classes of neutral lipids.
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Introduction
The endoplasmic reticulum (ER) plays a crucial role in protein qual-
ity control and lipid biosynthesis within the cell. When altered cellu-
lar states perturb ER functions, a phenomenon termed “ER stress”
activates signal transduction pathways collectively known as the
unfolded protein response (UPR) [1,2]. The UPR is comprised of
three core stress transducers, namely ER-resident transmembrane
proteins inositol-requiring enzyme 1a (IRE1a), pancreatic ER
eukaryotic translation initiation factor (eIF)-2a kinase (PERK) and
activating transcription factor (ATF)6. These transducers function to
reduce ER stress by upregulating transcripts that control protein-
folding capacity within the ER, promote degradation of misfolded
proteins via ER-associated protein degradation (ERAD) and regulate
biogenesis of the ER membranes [3].
Stimulation of membrane phospholipid synthesis during UPR has
been shown to require the transcription factor X-box binding protein
1 (XBP-1) [4], a downstream target of IRE1a to regulate free fatty
acid, triglyceride and cholesterol synthesis [5,6]. Sterol regulatory
element-binding proteins (SREBPs) are transcription factors that
regulate the expression of genes involved in lipid synthesis and
signalling networks to maintain lipid metabolism and homeostasis
within the cell [7–9]. SREBPs are implicated in numerous patho-
genic processes such as obesity, diabetes mellitus, non-alcoholic
fatty liver disease, non-alcoholic steatohepatitis, neurodegenerative
diseases and cancer [10]. During ER stress, PERK-mediated (eIF)-2a
phosphorylation causes SREBP activation [11,12]. Similarly, the
main ER stress regulator, the chaperone 78 kDa glucose-regulated
protein (GRP78, also known as BiP), suppresses ER stress-regulated
SREBP activation in the liver and improves hepatic steatosis and
insulin sensitivity [13]. Thus, the UPR collectively coordinates
protein quality control as well as lipid biosynthesis during ER stress
to re-establish cellular homeostasis. A number of studies have estab-
lished a mechanistic link between UPR and dysregulation of sphin-
golipid metabolism, and it is thought that these processes can
contribute to the development of inflammatory diseases [14–16].
Lipids may also serve as an important source of immunological
antigens. CD1 molecules, a family of MHC class I-like glycoproteins,
are specialized in presenting self- and non-self-lipids to T lympho-
cytes [17]. The human genome encodes five CD1 genes, CD1a,
CD1b, CD1c, CD1d and CD1e, whereas only CD1d is expressed in
rodents. In the ER, nascent CD1 heavy chains are folded and
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assembled with b2-microglobulin (b2m) in a process coordinated by
the ER chaperones calnexin and calreticulin [18,19]. Proper folding
and stabilization of CD1b and CD1d is thought to be facilitated by
the loading of phospholipids derived from the ER membrane [20,21]
and is mediated by an ER chaperone called microsomal triglyceride
transfer protein (MTP) [22]. Invariant natural killer T (iNKT) cells
are a specialized subset of T cells that recognize self- and foreign
lipids presented by CD1 molecules [23,24]. A hallmark is their abil-
ity to secrete large amounts of T helper (Th)1, Th2 and Th17 cytoki-
nes as well as chemokines shortly after activation [25].
Consequently, iNKT cells have been suggested to play a role in
either the amelioration or exacerbation of disease models like type I
diabetes, lupus, cancer, asthma, atherosclerosis, rheumatoid arthri-
tis, experimental autoimmune encephalomyelitis (EAE) and
inflammatory bowel disease (IBD) [25,26]. Most murine and human
iNKT cells recognize a non-self-glycosphingolipid called a-galacto-
sylceramide (a-GalCer) [27] which induces strong NKT cell activa-
tion. However, to date, no microbial or self-lipid antigen has been
described with similarly potent antigenic capacity. In this study, we
demonstrate that the IRE1a or PERK pathway within APCs induces
a lipid biosynthetic program that regulates the generation of distinct
classes of endogenous neutral lipids. Moreover, neutral lipids gener-
ated under ER stress are loaded onto CD1d, leading to potent iNKT
cell stimulation, highlighting a novel endogenous mechanism
responsible for triggering these immunomodulatory T cells.
Results
ER-stressed APCs promote iNKT cell activation
The UPR is accompanied by upregulation in lipid synthesis enzymes
suggesting that lipid synthesis is needed for resolving ER stress [28–
30]. However, whether this process impacts generation of immuno-
genic lipid antigens is unknown. To test this hypothesis, we initially
cultured murine and human macrophage cell lines with chemical
agents known to induce UPR such as thapsigargin or tunicamycin,
R848 or LPS at various time points, washed them and then co-
cultured them with iNKT cell hybridomas. As shown in Fig 1, treat-
ment of the macrophage cell lines J774.2 and U937 results in strong
activation of the NKT cell hybridoma N38-2C12. The strongest iNKT
cell autoreactivity was detected with thapsigargin-treated macro-
phages (for 4 h) when compared to tunicamycin or LPS, whereas
R848- or DMSO-treated cells displayed negligible levels of IL-2 cyto-
kine release (Figs 1A and B, and EV1A). Despite the extensive wash-
ing procedure, we cannot exclude the potential presence of residual
spore fractions of tunicamycin or thapsigargin in the medium of the
macrophages, which could have been sufficient to trigger iNKT
cells. Therefore, as a control, we directly incubated iNKT cell hybri-
doma cells in a CD1d protein-bound plate loaded with tunicamycin
or thapsigargin. However, here we found no induction of IL-2
(Fig EV1B). Analysis of UPR inducers in other murine cell lines
(such as the B-lymphoma (Bcl-1) or fibroblast (L929) cell lines) con-
firmed that stressed cells induce NKT cell activation, suggesting that
the observation was not restricted to macrophages only, but that in
general induction of UPR in diverse APCs is associated with iNKT
activation (Fig EV1C and D). Moreover, our results also exclude the
effect of apoptosis-mediated iNKT activation because there was no
difference in Annexin V levels, and importantly, blocking apoptosis
using a pan-caspase inhibitor had no effect on IL-2 secretion by
2C12 cells (Fig EV1E and F).
We next examined whether UPR induction within primary
macrophages regulates TCR-dependent iNKT activation. For these
experiments, murine bone marrow-derived macrophages (BMDM)
and human peripheral-derived macrophages were stimulated
in vitro with either thapsigargin or tunicamycin, and subsequently
co-cultured with murine or human CD1d tetramer-sorted iNKT cells
from C57Bl/6 mice or healthy human peripheral blood, respectively.
As shown in Fig 1C and D, the primary murine and human APC
undergoing UPR induces mixed Th1 and Th2 cell-type iNKT cyto-
kine responses, whereas type 17 cytokines were not induced. Inter-
estingly, intravenous (i.v.) administration of PLGA nanoparticles
loaded with thapsigargin significantly increased the levels of IL-4
and IFN-c cytokine-positive iNKT cells in the liver of CD57Bl/6 mice
as compared to vehicle-treated particles (Fig 1E). Collectively, these
results suggest that UPR inducers cause primary APCs to potently
activate both mouse and human iNKT cells leading to IL-4 and IFN-c
release.
UPR-induced iNKT cell activation is CD1d-dependent
iNKT cells are prototypic innate-like T cells, and as such, their acti-
vation may occur through cytokine-dependent activation such as IL-
12 or by glycolipid-mediated TCR recognition through CD1d presen-
tation [31–33]. We therefore evaluated the nature of the observed
iNKT cell autoreactivity upon UPR stress. First, we co-cultured NKT
cell hybridoma N38-2C12 with J774.2 stimulated with either thapsi-
gargin or a-GalCer in the presence of CD1d blocking monoclonal
antibody or an isotype control Ab (Fig 2A). The results indicate that
thapsigargin-induced NKT cell activation relies on CD1d, and the
degree of NKT cell activation was comparable with the response
elicited by the strong prototypic agonist a-GalCer. To evaluate
whether inflammatory cytokines produced by APCs undergoing UPR
might be involved in the observed iNKT activation, we first
performed cytokine arrays in supernatant collected from primary
macrophages treated with thapsigargin or tunicamycin. This assay
provided evidence that the ER-stressed macrophages produced
negligible levels of cytokine release except for IL-6 and TNF-a
(Fig EV2A). We confirmed these findings by performing co-cultures
of NKT hybridomas in the presence of J774.2 cell line with CD1d
knockdown and with primary macrophages derived from CD1d/
mice stimulated with thapsigargin. Both resulted in reduced iNKT
cell autoreactivity versus the untransfected parental cell line or
primary macrophages derived from CD1d+/+ mice, respectively
(Fig 2B and C). Theoretically, enhanced iNKT cell autoreactivity
may occur secondary to changes in surface levels of CD1d on APC
during ER stress. We therefore analysed the CD1d surface expres-
sion by APCs treated with thapsigargin (Fig EV3A and B). The data,
however, indicate that CD1d surface expression by APCs remains
unaltered during ER stress. Furthermore, we have been able to
exclude a role for direct effect of thapsigargin or tunicamycin in
binding CD1d and activating iNKT cells as drug addition into plate-
bound CD1d proteins failed to activate iNKT cells (Fig EV1B). Taken
together, these findings point to a strong induction of iNKT cell
autoreactivity in response to UPR activators in APCs, which is
strictly CD1d-dependent.
2 of 14 EMBO reports e48927 | 2020 ª 2020 The Authors
EMBO reports Srinath Govindarajan et al
IRE1a and PERK control UPR-induced iNKT cell activation
During ER stress, UPR transmits survival signals through three
sensory systems, PERK, IRE1a and ATF6 cascades to restore
cellular homeostasis. To assess activation of these UPR pathways
in macrophages in response to thapsigargin or tunicamycin, we
analysed the expression of the three sensors and a relevant down-
stream target gene by qPCR analyses. As expected, the three
sensors as well as the XBP1/ATF6 downstream target gene Bip
and the PERK downstream target gene Chop were strongly
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Figure 1. iNKT cell activation by antigen-presenting cells undergoing UPR.
A, B Bar graph represents IL-2 secretion by NKT cell hybridoma (2C12) co-cultured with (A) a murine macrophage cell line (J774.2) or with (B) a human macrophage cell
line (U937) treated with either thapsigargin (black bars), tunicamycin (red bars) or DMSO (white bars). Graphs show mean  SEM from n = 3 biological replicates.
****P < 0.0001 (unpaired t-test).
C, D The heat map represents cytokine secretion by in vitro expanded (C) murine splenic iNKT cells or (D) human peripheral blood iNKT cells co-cultured either with
thapsigargin- or tunicamycin- or DMSO-treated murine BMDMs. The heat map shows the average result of two pooled biological replicates.
E Wild-type C57BL/6 mice were injected intravenously with thapsigargin-loaded PLGA nanoparticles or vehicle, and 12 h later, hepatic iNKT cells were analysed by
flow cytometry. Histograms represent expression of intracellular IL-4 and IFN-c levels in hepatic iNKT cells from mice injected with thapsigargin-loaded PLGA
nanoparticles (red histogram) or vehicle-treated (grey histogram) mice. Dot plots represent MFI for intracellular IL-4 and IFN-c expression in hepatic iNKT cells
from thapsigargin-loaded PLGA nanoparticles (red dots) or vehicle-treated (black dots) mice. Data plots show mean  SEM from n = 5 mice per group. **P ≤ 0.001
(Mann–Whitney U-test).
Source data are available online for this figure.
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induced by thapsigargin and tunicamycin (Fig 3A and B). The
UPR signalling pathways and activation of IRE1a-XBP1 or PERK-
ATF4 or ATF6a have roles in controlling the transcriptional regu-
lation of genes involved in lipid metabolism [34–38]. We there-
fore sought to delineate the functional impact of interfering with
the different UPR sensory systems through genetic and pharmaco-
logical approaches.
To understand which UPR signalling arm promotes the highest
degree of iNKT cell activation, we performed co-cultures of NKT
cell hybridomas with J774.2 cells treated with inhibitors of IRE1a
(4l8c) [39], PERK (GSK2606414) [40] or AFT6a (Ceapin-A7)
[41]. As shown in Fig 3C, chemical inhibition of IRE1a or PERK
resulted in a significant reduction in IL-2 secretion by iNKT
hybridoma versus controls (Fig 3C). By contrast, inhibition of the
ATF6a had no effect on the activation of iNKT cells. Further,
co-culture of NKT cell hybridoma with control versus IRE1a or
PERK shRNA knockdown J774.2 cells (for validation of the
knockdown, see Fig 3D) resulted in a decreased cytokine produc-
tion by iNKT cells (Fig 3E). Overall, whereas initial studies impli-
cated UPR inducers in antigenicity of iNKT cells, this study now
directly implicates specific arms of the UPR in APCs leading to
iNKT cell activation. Thus, CD1d-dependent activation of iNKT
cells by APCs requires both the IRE1a and PERK branches of the
UPR.
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Figure 2. Autoreactivity of iNKT cell is CD1d-dependent.
A Thapsigargin- or a-GalCer-treated J774.2 cells were co-cultured with 2C12 in the presence or absence of the murine CD1d-specific antibody (black circles) or isotype
(red squares) for 16 h. The addition of an anti-CD1d antibody blocked the activation of 2C12 demonstrating that the NKT cell activation was CD1d-specific. Graphs
show mean  SEM from n = 2 biological replicates.
B Bar graph represents IL-2 secretion by NKT cell hybridoma (2C12) co-cultured murine macrophage cell line (J774.2) treated either with thapsigargin- or tunicamycin-
treated CD1d knockdown (white bars) or untransfected (black bars). Knockdown of CD1d blocked IL-2 secretion by 2C12. In total, n = 2 biological replicates were
performed (three technical replicates per biological replicate). Graphs show mean  SEM of each biological replicate.
C Bar graph represents IL-2 secretion by NKT cell hybridoma (2C12) co-cultured either with thapsigargin- or tunicamycin-treated primary BMDM isolated from CD1d/
(white bars) or wild-type (black bars) mice. 2C12 co-cultured with CD1d/ BMDMs resulted in reduced IL-2 secretion. Graphs show mean  SEM from n = 3
biological replicates. ***P < 0.001 (unpaired t-test).
Source data are available online for this figure.
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UPR-induced endogenous neutral rather than polar lipids
activate iNKT cells
We reasoned that (an) appropriate endogenous lipid antigen(s)
should be contained within lipid extracts from J774.2 cells treated
with UPR inducers, since cells undergoing ER stress can be effi-
ciently recognized by iNKT cells. To identify lipid species gener-
ated during UPR with the highest immunogenic potential, total
lipids were isolated from macrophages treated with either thapsi-
gargin or tunicamycin using a modified Folch extraction protocol
[42]. The resulting organic fractions were further fractionated using
solid-phase extraction (SPE) cartridges [43] and tested for their
ability to stimulate NKT hybridomas. Plate-bound mCD1d protein
was pre-incubated with the lipid fractions and then washed to
remove unbound material prior to the addition of the iNKT cells.
Pre-treatment of the mCD1d fusion protein with the lipid fractions
1–3 of the thapsigargin- or tunicamycin-treated J774.2 cells
resulted in a markedly augmented IL-2 release by the NKT
hybridomas compared to the mCD1d fusion protein treated with
control lipid fractions (Fig 4A). In contrast, the mCD1d fusion
protein pre-incubated with the lipid fractions 4–6 induced only a
small increase in IL-2 production (Fig 4A). Further HPLC-Q-TOF-
MS analyses verified that the SPE fractionation resulted in a clear
separation of non-polar lipids DAG and ceramide from the polar
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Figure 3. Autoreactivity of iNKT cell requires both the IRE1a and PERK pathway.
A, B qPCR analyses showing the expression (fold induction) of UPR signature genes compared to DMSO in murine and human macrophage cell lines, J774.2 (A) and
U937 (B) stimulated with either thapsigargin, tunicamycin or DMSO for 4 or 8 h. Graphs show mean  SEM from n = 2 biological replicates (two technical
replicates per biological replicate).
C Bar graph represents percentage of IL-2 secretion by NKT cell hybridoma (2C12) co-cultured with murine macrophage cell line (J774.2) treated with either
thapsigargin or tunicamycin in the presence of IRE1a inhibitor (4l8c) (black bar) or PERK inhibitor (GSK) (grey bar) or ATF6a inhibitor (Ceapin-A7) (red bar),
respectively. Inhibition of IRE1a or PERK resulted in significant reduction in IL-2 secretion by iNKT hybridoma compared to controls. In total, n = 2 biological
replicates were performed (two and four technical replicates per biological replicate, respectively). Graphs show mean  SEM of each biological replicate.
D Immunoblots represent the knockdown efficiency for IRE1a and PERK protein in J774.2 cell line transduced with lentiviral particles carrying gRNA against the IRE1a
or PERK gene.
E Bar graph represents percentage of IL-2 secretion by NKT cell hybridoma (2C12) co-cultured with thapsigargin-treated murine IRE1a or PERK knockdown
macrophage cell line (J774.2). Knockdown of IRE1a (black bar) or PERK (grey bar) resulted in significant reduction in IL-2 secretion by iNKT hybridoma. In total,
n = 2 biological replicates were performed (three technical replicates per biological replicate). Graphs show mean  SEM of each biological replicate.
Source data are available online for this figure.
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sphingolipids including monohexosylceramide and sphingomyelin
(Fig EV4). Based on these findings, we concluded that the iNKT
cell activation was not caused by the polar lipids, but rather by the
neutral lipids. Previous reports have suggested that CD1d protein
undergoes acidification during the process of antigen loading in
intracellular compartments [44,45]. We therefore sought to exam-
ine the effect of acidic pH on endogenous antigen presentation by
the mCD1d protein. Murine CD1d fusion protein was incubated
with fractionated lipid fractions diluted into citrate/phosphate
buffer solutions having pH 7.0 or pH 4.0 at a different ratio of anti-
gen to protein and assayed for recognition by iNKT cells (Fig 4B).
Recognition of the neutral lipid fractions was enhanced approxi-
mately twofold after antigen pre-incubation at pH 4.0 compared to
a neutral pH 7.0. Maximal IL-2 release was reproducibly observed
for the neutral lipid fractions pre-incubated at pH 4.0, while IL-2
production was significantly lower for polar lipid fractions pre-
incubated at pH 4.0 (Fig 4B). To determine if the neutral lipid frac-
tions can activate primary iNKT cells, we performed the CD1d
plate assay using fractionated lipids isolated either from murine or
human primary macrophages. The experiment was performed by
loading mCD1d and huCD1d fusion protein with the neutral lipid
fractions isolated from thapsigargin-treated murine or human
primary macrophages, respectively, at pH 4.0 and subsequently co-
cultured with murine or human CD1d tetramer-sorted and polar-
ized NKT cells from C57Bl/6 mice or healthy human peripheral
blood, respectively. The results showed increased IFN-c release by
NKT1 cells isolated from C57Bl/6 mice or healthy human periph-
eral blood, respectively, when compared to the CD1d fusion
protein treated with DMSO-treated lipid fractions (Fig 4C and D).
In contrast, the murine and human CD1d fusion protein pre-incu-
bated with the polar lipid fractions induced only a small increase
in IFN-c production (Fig 4C and D). In addition, loading of murine
CD1d fusion protein either with the neutral or polar lipid fractions
resulted in less or no significant IL-4 release by NKT2 cells
compared to the CD1d fusion protein treated with DMSO-treated
lipid fractions (Fig EV2B). We therefore concluded that the neutral
lipid fractions isolated from thapsigargin-treated macrophages are
able to steer NKT cells towards Th1 responses.
UPR-mediated iNKT activation requires endosomal/lysosomal
recycling of CD1d molecules
The acquisition of self-antigens may occur at distinct intracellular
sites as CD1d can traffic through sections of the endosomal vesic-
ular system before being re-expressed at the cell surface. Hence,
recycling of CD1d between various endomembrane compartments
and the cell surface for antigen presentation depends upon the
tyrosine motif present in the cytoplasmic tail of CD1d [46]. We
therefore assessed the impact of internationalization and recycling
of CD1d by comparing responses of UPR in CD1d-transfected
APCs (A20 CD1d) in the presence or absence of this cytoplasmic
sorting tyrosine motif [(A20 tail deleted (TD) CD1d]. As shown
in Fig 5A, ER-stressed APCs elicited markedly lower levels of
iNKT cell autoreactivity when lacking the cytoplasmic tail of
CD1d. Studies have shown that during inflammation and infec-
tion, iNKT activation is controlled by rapid degradation of the
two catabolic enzymes such as ASAH1 acid ceramidase and
GLA/GAA a-glycosidase, which leads to the accumulation of
stimulatory endogenous glycosphingolipids [47,48]. We therefore
investigated whether ER-stressed macrophages downregulate tran-
scripts encoding glycosphingolipids-degrading enzymes such as
acid ceramidase (ASAH1), a-glucosidase (GAA) and a-galactosi-
dase (GLA). Our results suggest that the transcripts of these cata-
bolic enzymes such as a-glucosidase (GAA), a-galactosidase
(GLA) and acid ceramidase (ASAH1) were reduced in thapsi-
gargin-treated J774.2 cells when compared to DMSO controls
(Fig 5B). Similarly, the inhibition of a-/b-glucosidases in J774.2
cells with castanospermine or deoxygalactonojirimycin resulted in
enhanced IL-2 secretion by 2C12 cells (Fig 5C). All together,
these data suggest that degradation of these catabolic enzymes
during UPR in macrophages leads to potential accumulation of
stimulatory glycosphingolipids. To further evaluate the nature of
the observed iNKT cell autoreactivity upon UPR stress linked to
synthesis of a-linked glycosylceramides [49], we co-cultured NKT
cell hybridoma 2C12 with J774.2 stimulated with either thapsi-
gargin or a-GalCer in the presence of L363 blocking monoclonal
antibody or an isotype control Ab (Fig 5D). In contrast to the
▸Figure 4. Fractionated neutral lipid from stimulated macrophages activates iNKT cells.A Neutral (Fractions 1–3) and polar lipids (Fractions 4–6) were isolated from J774.2 macrophages stimulated with thapsigargin, tunicamycin or DMSO. Lipids were
fractionated using solid-phase extraction (SPE) cartridges. Bar graph represents NKT cell activation by CD1d protein-bound neutral lipids fractions isolated from
thapsigargin (black bars)- or tunicamycin (red bars)-treated J774.2 cells. Polar lipid fractions induce very little IL-2 secretion by 2C12. In total, n = 2 biological
replicates were performed (two technical replicates per biological replicate). Graphs show mean  SEM of each biological replicate.
B Graph represents enhancement of loading with neutral lipid fractions isolated from thapsigargin-treated J774.2 at acidic pH and reduced mCD1d loading at neutral
pH. Graphs show mean  SEM from n = 2 biological replicates (two technical replicates per biological replicate).
C Neutral (Fractions 1–3) and polar lipids (Fractions 4–5), isolated from murine bone marrow-derived macrophages stimulated with thapsigargin or DMSO and
fractionated using solid-phase extraction (SPE) cartridges, were co-cultured with purified NKT1 subsets. Bar graphs represent IFN-c release by NKT1 cells induced by
CD1d protein-bound neutral lipid fractions isolated from thapsigargin (black bars)- or DMSO (white bars)-treated primary murine macrophages. Polar lipid fractions
induce a minimal amount of IFN-c secretion by the NKT1 sublineage. In total, n = 2 biological replicates were performed (two technical replicates per biological
replicate). Graphs show mean  SEM of each biological replicate.
D Neutral (Fractions 1–3) and polar lipids (Fractions 4–5) were isolated from primary macrophages derived from human peripheral blood stimulated with thapsigargin
or DMSO and fractionated using solid-phase extraction (SPE) cartridges. Bar graph represents IFN-c release by NKT1 cells by CD1d protein-bound neutral lipid
fractions isolated from thapsigargin (black bars)- or DMSO (white bars)-treated human primary macrophages. Polar lipid fractions induce only minimal amounts of
IFN-c secretion by the NKT1 sublineage. In total, n = 2 biological replicates were performed (two technical replicates per biological replicate). Graphs show
mean  SEM of each biological replicate.
Source data are available online for this figure.
6 of 14 EMBO reports e48927 | 2020 ª 2020 The Authors
EMBO reports Srinath Govindarajan et al
clear inhibition of IL-2 secretion by 2C12 hybridoma when J774.2
macrophage cells incubated with a-GalCer were treated with the
L363 antibody, no such effect was observed in thapsigargin-
treated cells. The results suggest that ER stress-mediated NKT cell
activation was due to generation of novel stimulatory endogenous
iNKT ligands but not due to the accumulation of a-linked glyco-
sylceramides.
Discussion
For several years, it has been known that CD1d-expressing APCs
can induce proliferation, cytokine secretion and/or cytolysis of
CD1d-restricted T cells in the absence of foreign antigen. This
autoreactivity was described in early studies for CD1a-, CD1c-
restricted T cells and later for group 2 or CD1d-restricted T cells
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[50,51]. However, while several microbially derived glycolipid
antigens have been discovered, highlighting the role of iNKT
cells in host defence, the mechanisms leading to generation of
endogenous lipid antigens are less clear. In this study, we reveal
that ER stress inducers as well as defined mediators of the UPR
in APCs play a pivotal role in CD1d-mediated iNKT cell
responses by generating endogenous neutral lipid antigens in
APCs able to trigger these cells. This implies two arms of the
UPR sensors, IRE1a-XBP1 and PERK-ATF4, which promote induc-
tion or accumulation of endogenous neutral lipids, in the activa-
tion of iNKT cells in a CD1d-dependent manner. This pathway
was found to be conserved in both mice and humans suggesting
an evolutionary important mechanism of iNKT cell stimulation
under sterile ER stress conditions.
The UPR plays an important immune role through a direct cross-
talk between ER stress-induced signalling pathways and immune
responses. The IRE1a/XBP1s axis regulates immune cell survival
and antigen-presenting abilities [52–54]. IRE1a regulates expression
of several members of the MHC-I antigen presentation pathway [55]
and also plays an important role in cross-presentation which may
predominantly connect to the phagosomal pathway [54]. Functional
studies with cDC1 and cDC2 cells show that antigen presentation
via MHC-II is unaffected in the absence of XBP1 [54]. However, in
ovarian cancer, XBP1 ablation in DCs results in infiltration of CD4+
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Figure 5. UPR-induced neutral lipids require CD1d endosomal/lysosomal recycling.
A Bar graph represents that recycling of CD1d between various endomembrane compartments and the cell surface is required for optimal IL-2 secretion by NKT cells. In
total, n = 2 biological replicates were performed (three technical replicates per biological replicate). Graphs show mean  SEM of each biological replicate.
B qPCR analyses showing the expression (fold induction) of genes encoding for glycosphingolipid degrading enzymes compared to DMSO in murine macrophage cell
lines J774.2 stimulated with either thapsigargin or DMSO for 8 h. In total, n = 2 biological replicates were performed (two technical replicates per biological replicate).
Graphs show mean  SEM of each biological replicate.
C Glycolipid processing in intracellular compartments is not required prior to presentation to NKT cells. IL-2 secretion in UPR-induced NKT cell activation in the
presence or absence of castanospermine or deoxygalactonojirimycin. Graphs show mean  SEM from n = 3 biological replicates. n.s (non-significant) (one-way
ANOVA) biological replicates.
D L363 antibody does not impact UPR-induced NKT cell activation. 2C12 NKT cells were co-cultured with ER-stressed macrophages J774.2 cells and treated with L363
antibody or isotype control. a-GalCer-induced responses served as positive control. In total, n = 2 biological replicates were performed (four technical replicates per
biological replicate). Graphs show mean  SEM of each biological replicate.
Source data are available online for this figure.
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T cells. This suggests a negative role of XBP1 in CD4+ T-cell activa-
tion under conditions of sustained ER stress [56]. The results
presented in this study indicate that the ER-stressed APCs also play
a role in activation of iNKT cells via CD1d, a prototypic non-clas-
sical MHC molecule. During ER stress, the components of UPR are
involved in the regulation of membrane lipid biosynthesis and ER
biogenesis to maintain cellular homeostasis [4,38]. We now show
that ER-stressed APCs also induce generation of endogenous lipid
antigens presented by CD1d molecules to iNKT cells. Thapsigargin-
mediated induction of UPR in macrophages was associated with
highest level of activation of CD1d-restricted iNKT cells when
compared to tunicamycin, R848 or LPS, which may be linked to
distinct mechanisms of action to perturb the ER function [57,58].
Activated stimulated iNKT cells are well known to produce large
quantities of type 1, type 2 as well as type 17 cytokines. In vivo, they
may impact diverse immune reactions in response to various patho-
gens and tumours [23,25,59–61]. In vitro UPR induction in APCs
activates both murine and human iNKT cells which in turn secrete
predominantly IL-4, IFN-c, along with IL-10 in mice. In vivo admin-
istration of thapsigargin-loaded nanoparticles also led to iNKT cell
activation as measured by intracellular cytokine production
(Fig 1E). Previous studies have demonstrated that intravenous (i.v.)
administered nanoparticles are sequestered largely by the Kupffer
cells in liver compared to other periphery organs [62]. Therefore,
we injected the most efficient biodegradable PLGA nanoparticles of
1 lm size loaded with thapsigargin to understand the in vivo inter-
action between Kupffer and iNKT cells. In line with the in vitro
results, administration of thapsigargin-loaded nanoparticles in mice
significantly increased IL-4 and IFN-c in hepatic iNKT cells when
compared to vehicle controls. Intriguingly, however, ER-stressed
APCs failed to induce IL-17 which is of particular interest as it
suggests that this pathway may not play a major role in the
inflammatory effector roles ascribed to iNKT17 cells but rather
impacts iNKT1 function.
Previously, we showed that the UPR sensor IRE1a plays a key
role in regulating cytokine production in iNKT cells by affecting
cytokine mRNA stability. This was restricted to certain iNKT cell
subsets: iNKT1 and iNKT17, but not iNKT2 cells, which were
impacted by IRE1a [63]. This illustrates that UPR has pleiotropic
and cell subset-dependent roles on the immune system. Because the
UPR and, particularly, IRE1a control cytokine production of iNKT
cells [63], we wanted to rule out that a similar mechanism would
also be in place in ER-stressed APCs. Hence, in addition to the
strong T-cell receptor (TCR) signal induced by high-affinity lipid
antigens which can activate iNKT cells directly in CD1d-dependent
manner, iNKT cells may also be activated by a weak TCR signal by
low-affinity lipid antigens in combination with cytokines such as IL-
12 secreted by the activated APC [33,64,65]. However, our data are
most consistent with a model that ER-stressed APCs induce iNKT
cell activation through a CD1d-dependent but cytokine-independent
mechanism. First, there was no direct effect of thapsigargin or tuni-
camycin in binding CD1d and activating iNKT cells. Second, the
UPR-mediated responses were clearly CD1d-dependent as demon-
strated by the CD1d blocking assays and the lack of response in
CD1d KO APC. Furthermore, ER-stressed APCs in the absence of
iNKT cells induced very little, if any, secretion of cytokines. There-
fore, it is more likely that exposure to ER stress inducers in APCs
results in generation of CD1d-restricted lipid antigens which trigger
iNKT cell responses. This mirrors the effect of the activation of
PERK as well as three other kinases of different stress pathways on
the immunopeptidome. By selective translation of mRNAs harbour-
ing upstream open reading frames in the 50 untranslated region,
tracer peptides were found to be processed and presented in MHC
class I molecules to antigen-specific T cells [66].
In addition to phospholipids, ER membrane also contains sphin-
golipids such as ceramide, sphingosine-1-phosphate (S1P) and
sphingosine. After identifying a-GalCer, a powerful marine sponge
sphingolipid antigen recognized in antigen screening [67], it was
found that iNKT cells can be activated by glycosphingolipids (GSL).
Endogenous sphingolipids have since been examined as potential
lipid antigens for iNKT cells. During ER stress, alteration in lipid
metabolism is needed in order to maintain homeostasis to prevent
ER stress [29]. Here, IRE1a, ATF6 and PERK appear to function
collectively and failure to do so results in the suppression of meta-
bolic genes involved in lipid metabolism. Of note, the liver-specific
deletion of X-box binding protein 1 (XBP1), a transcription factor
activated by IRE1, resulted in a profound hypocholesterolaemia and
hypotriglyceridaemia in adult mice, suggesting that de novo synthe-
sis of lipids in the liver is regulated in part by XBP1[4]. Studies have
shown that PERK-mediated eIF-2a phosphorylation results in activa-
tion of C/EBP and peroxisome proliferator-activated receptor-c
(PPARc), which contribute to the induction of lipogenic genes. Also,
the PERK-ATF4 pathway plays an important role in promoting lipo-
genesis both in the liver and other tissues such as adipose tissue
[10,35,37]. However, the functional significance of the interactions
between altered lipid metabolism regulated by UPR and other
immune cells has not been explored in detail. Our data suggest that
activation of IRE1a-XBP1 and PERK-ATF4 pathways to restore ER
homeostasis within APCs and the resulting lipid metabolic pheno-
type promotes an ER stress-adapted CD1d-restricted T-cell response.
These findings suggest that failure of the UPR to restore ER stress
perturbs CD1d-restricted NKT cell biology which may contribute to
chronic inflammatory diseases. In future work, this hypothesis
could be explored in relevant disease models.
The search for novel intracellular lipid antigens capable of acti-
vating CD1d-restricted T cells has been the subject of intense
research interest. Although a few candidate endogenous lipid anti-
gens have been identified, most activate CD1d-restricted T cells only
very weakly [61]. A major difficulty in identifying novel lipid anti-
gens with high immunogenic potential is that such candidate lipids
are expressed at very low concentrations in resting, or even stimu-
lated antigen-presenting cells. Our findings are novel in the sense
that we have identified a cellular state, namely ER stress, during
which immunogenic neutral lipids capable of activating CD1d-
restricted T cells are generated. Furthermore, in vitro CD1d plate-
bound assays suggest that neutral lipids generated during UPR
require acidic pH for efficient loading to CD1d. Consistent with
earlier studies [46,68], it is likely that under lower pH conditions,
the binding groove of mCD1d protein might be more exposed to
solvent, resulting in better binding of antigens compared to neutral
pH. Moreover, our A20CD1dTD assays suggest that CD1d protein
translocation between intracellular compartments and the cellular
membrane is required for optimal iNKT activation during UPR.
Previous studies have shown that degradation of the catabolic
enzymes namely ASAH1 or GAA or GLA controls the activation of
iNKT cells by accumulating a-GalCers [49]. Surprisingly, our in vitro
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assays using the L363 antibody suggest other potential endogenous
glycosphingolipids are accumulated during UPR in macrophages
which resulted in activation of iNKT cells. Consistent with our find-
ings, a recent study [69] shows that ER-stressed macrophages
require CD1d recycling in the endosome and lysosome for optimal
iNKT activation. Even though our results suggest an upregulation of
endogenous lipids bound to CD1d molecules during UPR that acti-
vate iNKT cells, whether ER stress implies local biosynthesis of new
agonist lipids, or it rather plays an indirect role in the upregulation
of molecular pathways related to the endo/lysosomal handling of
lipids to CD1d warrants further investigation. Studies have shown
that in addition to iGB3 or endogenous a-GalCer other glycosphin-
golipids may also involve in selecting iNKT cells in thymus during
its development [49,70]. However, identification of those endoge-
nous ligands that promote positive selection of iNKT cells remains
unclear. Since ER stress in thymocytes facilitates their survival [71],
there is a more likely possibility that UPR-mediated accumulation of
endogenous glycosphingolipids may be involved in positive selec-
tion of iNKT cells in thymus. Therefore, identification of endoge-
nous ligands generated during UPR may facilitate better
understanding of thymic iNKT cell development. Also, given the
myriad of inflammatory diseases linked to the UPR pathway, our
data suggest that the UPR-mediated induction of endogenous glycol-
ipids provides a long-sought-after mechanism for how UPR may
impact chronic inflammatory diseases such as inflammatory bowel
diseases or hepatitis.
Materials and Methods
Mice
C57BL/6 and CD1d1/2/ (B6 background) mice were purchased
from Jackson Laboratory (USA). All mice were maintained under
specific pathogen-free conditions in the Animal Care Facility of
Ghent University. Experiments were performed with age- and
sex-matched mice at 10–12 weeks of age. All experiments were
approved by the Institutional Animal Care and Ethics Committee.
Flow cytometry and antibodies
iNKT cells were sorted on FACSAria III (BD Biosciences). Murine
antibodies used were CD19-PerCP-Cy5.5 (eBio1D3), bTCR-FITC
(H57-597), CD4-APC-eFluor780 (RM4-5), CD8a-e450 (53-6.7), IL4-
FITC (11B11), IFNc-FITC (XMG1.2), MHC-II-FITC (114.15.2), F4/80-
PE (BM8), CD170-APC (IRNM44N), CD11C-PE-Cy7 (N4/8) and
Ly6G-PE Texas red (all from Thermo Fisher scientific); CD11b-APC-
Cy7 (M1/70), Ly6C-BV510 (HK1.4), CD45-BV605 (30-F11), and
CD1d-e450 (1B1) (all from BD). Human antibodies used were
TCRVb11-FITC (C21) and 7-AAD-PerCP-Cy5.5 (all from BD). iNKT
cells were stained at 4°C for 30 min using a-GalCer-loaded CD1d
tetramers provided by NIH Tetramer Core Facility, USA, followed by
antibody staining. iNKT cells are defined as iNKT (TCRb+CD1d-
aGC+); for Annexin V, staining set (Thermo Scientific) was used
according to the manufacturer’s instructions. For intracellular
proteins, the FoxP3/transcription factor staining buffer set
(eBioscience) was used according to the manufacturers’
recommendations.
Cell suspension preparations
Single-cell suspensions from murine spleen were resuspended in
PBS and layered over Ficoll gradients. Human peripheral blood
mononuclear cells (PBMCs) were isolated by layering the whole
blood over Ficoll–Paque. iNKT cells were enriched by using mouse
CD5 (Ly-1)-microbeads (Miltenyi Biotec) or human untouched T
cells-Dynabeads (Invitrogen), respectively, and resuspended in PBS
containing 1 mM EDTA and 0.5% BSA.
Cell culture
J774.2 and U937 cell lines from ATCC were cultured in DMEM or
RPMI-1640 with 10% FBS, 2 mM glutamine, and 100 units/ml peni-
cillin and streptomycin (all from Gibco) (complete medium). 2C12
hybridoma was obtained from Mitch Kronenberg (La Jolla Institute
for Allergy and Immunology) and cultured in complete DMEM
supplemented with 5.5 × 102 lM l-ME, (Sigma-Aldrich). Bone
marrow-derived macrophages (BMDMs) were isolated from C57BL/
6 or CD1d/ mice by flushing the femur and tibia with RPMI-1640
medium. The bone marrow cells were resuspended in complete
RPMI-1640 medium supplemented with 40 ng/ml murine M-CSF.
Cells were cultured in petri dishes for 8 days at 37°C and 5% CO2
with medium change every 3 days. Human peripheral-derived
macrophages were isolated by layering whole blood over Ficoll–
Paque. Isolated peripheral mononuclear cells were resuspended in
complete RPMI-1640 medium supplemented with 40 ng/ml human
M-CSF. Cells were cultured in petri dishes for 6 days at 37°C and
5% CO2 with medium change every 2 days. For all co-culture exper-
imental setups, J774.2 or U937 or primary macrophages cells were
plated at a density of 1.0 × 105 cells/well in flat-bottom 96-well
plate and stimulated with thapsigargin (50 nM) or tunicamycin
(3 lg/ml) or DMSO (all from Sigma-Aldrich) for 4 and 8 h in
complete DMEM or RPMI-1640 medium. For blocking experiments,
the J774.2 cells were incubated with thapsigargin (50 nM) in the
presence or absence of 10 lg/ml murine anti-CD1d (1B1) or a-
GalCer-CD1d complex (L363) antibody for 8 h. For inhibitors stud-
ies, the J774.2 cells were incubated with thapsigargin in the pres-
ence of castanospermine (50 nM) or deoxynojirimycin (50 nM).
After incubation, cells were washed twice with PBS and a total of
0.5 × 105 iNKT cells or 2C12/well resuspended in complete RPMI-
1640 or DMEM supplemented with 5.5 × 102 lM l-ME were added.
Supernatants were collected after 16 h of co-culture and used for
cytokine measurements by ELISA or by using fluorescence-encoded
beads (LEGENDplex).
In vitro expansion of iNKT cells
Sorted murine splenic bulk iNKT cells were resuspended in
complete RPMI-1640 medium containing 5.5 × 102 lM l-ME,
murine IL-2 (10 ng/ml), IL-12 (1 ng/ml) and soluble a-CD28 (5 lg/
ml; all from Thermo Fisher Scientific) and stimulated with plate-
bound a-CD3e (3 lg/ml) for 2 days. Cells were then rested for
2 days and resuspended in complete RPMI-1640 medium containing
5.5 × 102 lM l-ME and murine IL-7 (2 U/ml; Thermo Fisher Scien-
tific) for 4 days. iNKT cells were then re-stimulated with plate-
bound a-CD3e (3 lg/ml) for a further 3 days and subsequently
expanded for an additional 10 days, as described before [72].
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Human iNKT cells were expanded by means of 6B11Ab (Thermo
Fisher) and IL-2 (Roche) as described before [73].
Administration of thapsigargin-loaded PLGA nanoparticles
5 mg of PLGA (poly lactic-co-glycolic acid), 2.5 ll DOPE-rhodamine
(10 mg/ml in ethanol) and 500 lg thapsigargin were dissolved in
200 ll dichloromethane and emulsified in a 0.1% aqueous polyvinyl
alcohol solution by ultrasonication. The resulting emulsion was
diluted with 20 ml of a 0.05% aqueous polyvinyl alcohol solution
and subsequently stirred 2 h at 40°C. The resulting solution was fil-
tered using a 40-lm filter to remove larger particulates. The sizes of
the particles (1 lm) were confirmed by optical microscopy. C57BL/
6 mice were tail vein injected with 200 ll of PLGA nanoparticles
suspension or 200 ll vehicle using 29-gauge insulin needle, and
hepatic iNKT cells were analysed 12 h post-injection by flow
cytometry.
Lentiviral production and lentiviral infection
Lentivirus production was performed by co-transfecting murine
Ern1 (K4522205) or Eif2ak3 (K4376505) or scrambled (K010)
pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro plasmid with the packaging
plasmid pLenti-P2A/P2B (LV003) in HEK293T cells using Lipofec-
tamine 2000 (Thermo Fisher Scientific). Lentiviral particles were
collected by following the manufacturer’s protocol for Lentiviral
Expression Systems (Applied Biological Materials Inc.). For lentivi-
ral infection, viral particles were mixed with 4 lg/ml polybrene and
added to J774.2 cell lines. After 48 h of infection, stable cells were
selected using puromycin at 2 lg/ml.
Quantitative real-time RT–PCR
RNA was extracted from J774.2 or U937 stimulated with thapsi-
gargin (50 nM) or tunicamycin (3 lg/ml) or DMSO (all from Sigma-
Aldrich) for 4 and 8 h using the miRNeasy Mini Kit (QIAGEN,
Valencia, CA). cDNA was produced and amplified using the Quanti-
Tect Whole Transcriptome Kit (QIAGEN, Valencia, CA). qPCR was
performed with the FastStart SYBR Green Master Mix (Roche, Basel,
Switzerland) and detected with a LightCycler 480 System (Roche,
Basel, Switzerland). Samples were normalized against at least 3 of
the following housekeeping genes: Rpl13a, Atp5b, Eif4b, Cyc1,
B2m, Ubc, Actb, Gapdh, Sdha or Tubb4a using qBasePlus software
(Biogazelle NV, Belgium). Primer sequences are listed in Table EV1.
Western blot
Cells were stimulated with thapsigargin (50 nM) (all from Sigma-
Aldrich) for 2 h. Cells were spun for 10 min at 400 g at 4°C. After
centrifugation, the medium was removed and washed with ice-cold
PBS. Cells were lysed for 15 min on ice in E1A buffer (1% NP40,
20 mM HEPES, pH 7.9, 250 mM NaCl, 1 mM EDTA and protease/
phosphatase inhibitors). Insoluble material was discarded by cold
centrifugation at 13,500 g, and a fixed amount of lysate was mixed
with sample buffer before separation by 10% SDS–PAGE. Gels were
transferred onto 0.45-lM nitrocellulose membranes (Bio-Rad). After
transferring to a membrane, proteins were incubated overnight in
the presence of anti-IRE1a or anti-PERK antibody (1:1,000; Cell
Signaling) at 4°C followed by incubation with horseradish peroxi-
dase-conjugated anti-rabbit IgG antibody (1:10,000; Cell Signaling)
for 1 h at room temperature. Protein bands were visualized by
enhanced chemiluminescence kit (Thermo Scientific). Membranes
were stripped for 15 min using stripping buffer (Cell Signaling) and
reprobed with anti-b-Actin antibody (1:1,000; Santa Cruz Biotech-
nology).
Fractionation of total lipids
50 × 106 of J774.2 or U937 or primary murine or human macro-
phage cells were treated for 8 h with 50 nM thapsigargin or DMSO.
After incubation, the cells were washed with cold PBS after which
they were pelleted and snap-frozen in dry ice. Pellets were resus-
pended in 2 ml PBS followed by the addition of 4 ml of chloroform
and methanol (1:1). After thorough mixing, the cells were centri-
fuged at 3,750 g for 10 min to remove insoluble/precipitated
protein. 1 ml of 50 mM citric acid, 2 ml of water and 1 ml of chloro-
form were added and centrifuged at 3,750 g for 20 min with brake.
The lower phase, containing lipids of interest, was transferred to a
new tube, dried down under a stream of nitrogen and resuspended
in the desired amount of chloroform. Amino-propyl columns
(SUPELCO Superclean LC-NH2-100 mg, 1 ml) were pre-equilibrated
with 2–3 ml n-hexane. Lipids in chloroform applied to the column.
The samples were allowed to adsorb to the matrix by percolation
through the cartridge by gravity. Lipid fractions were then eluted
sequentially as follows: Fraction 1 was eluted with 1.4 ml of ethyl
acetate–hexane 15:85; Fraction 2 was eluted with 1.6 ml of chloro-
form–methanol 23:1 (v/v); Fraction 3 with 1.8 ml of diisopropyl
ether–acetic acid 98:5 (v/v); Fraction 4 with 2 ml of acetone–
methanol 9:1.35 (v/v); and Fraction 5 with 2 ml chloroform–
methanol 2:1 (v/v). The fractions were then dried by passing a
stream of nitrogen gas and used for further analyses.
CD1d plate-bound assay
Fractionated lipids isolated either from thapsigargin- or DMSO-
treated J774.2 cells were dried by passing a stream of nitrogen gas
and then resuspended in 50 mM pH 4 or pH 7 citrate buffer supple-
mented with 0.25% CHAPS. The lipid was then mixed with biotiny-
lated CD1d (provided by the NIH Tetramer Facility) that was also
diluted into citrate-CHAPS. Lipids were then bound to CD1d for
overnight, after which the pH was adjusted to 7.4 with 1 M Tris pH
9. For binding CD1d onto 96-well plates, 5 lg of CD1d protein was
added per well for 1 h at room temperature. Plates were then exten-
sively washed with sterile 1× PBS before the addition of
50 × 104 N38-2C12 hybridoma cells or primary murine or human
expanded NKT1 per well in complete RPMI medium. After 16-h
incubation at 37°C and 5% CO2, supernatants were then collected
and analysed for IL-2 by ELISA or by using fluorescence-encoded
beads (LEGENDplex).
Mass spectrometry
The solid-phase extraction purified fractions of thapsigargin-treated
macrophages were weighed and normalized to 1 mg/ml in the
mobile phase solvent A (see below). The samples (10 ll injection)
were run on an Agilent Poroshell 120 A, EC-C18, 3 × 50 mm, 1.9 lm
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reverse-phase column equipped with an Agilent EC-C18, 3 × 5 mm,
2.7 lm guard column and analysed by using Agilent 6530 Accurate-
Mass Q-TOF/1260 series HPLC instrument. The mobile phases were
(A) 2 mM ammonium formate in methanol/water (95/5; V/V) and
(B) 3 mM ammonium formate in 1-propanol/cyclohexane/water
(90/10/0.1; v/v/v). In a 20-min run, the solvent gradients are as
follows: 0–4 min, 100% A; 4–10 min, from 100% A to 100% B; 10–
15 min, 100% B; 15–16 from 100% B to 100% A; 16–20 min, 100%
A. All the lipid standards diacylglycerol (DAG, D0138) and linoleic
acid (18:2 FA, L1376) were purchased from Sigma-Aldrich. C18 cera-
mide (d18:1/18:0) (#860518), C24:1 galactosylceramide (d18:1/24:1)
(#860546) and C24:1 sphingomyelin (SM, #860593) were purchased
from Avanti Polar Lipids.
Statistical analysis
Statistical testing was performed using GraphPad Prism software.
Data availability
No primary datasets have been generated and deposited.
Expanded View for this article is available online.
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